跳至主要内容
临床试验/CTRI/2021/03/031724
CTRI/2021/03/031724进行中(未招募)未知

actobacillus Rhamnosus GG to reduce NEC, sepsis and mortality in VLBW infants –A Randomised Controlled Trial ?

Surya Mother and child superspeciality hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Infants with birth weight <1500 g [very low birth weight infants (VLBW)] who are started on enteral feeds.
  • 2.Gestational age < 32 weeks
  • 3.Hemodynamically stable

排除标准

  • 1.Infants who have gastrointestinal anomalies
  • 2.Severe birth asphyxia (defined as APGAR score <3 at 5 minutes)
  • 3.Cyanotic congenital heart disease
  • 4.Those not started on feeds by 14 day of life
  • 5.Gestational age > 32 weeks
  • 6.Hemodynamically unstable
  • 7.Congenital anomalies

研究者

发起方
Surya Mother and child superspeciality hospital

相似试验